FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2978156688> ?p ?o ?g. }

• W2978156688 abstract "Abstract Background The current World Health Organization classification recognises 12 major subtypes of renal cell carcinoma (RCC). Although these subtypes differ on molecular and clinical levels, they are generally managed as the same disease, simply because they occur in the same organ. Specifically, there is a paucity of tools to risk-stratify patients with papillary RCC (PRCC). The purpose of this study was to develop and evaluate a tool to risk-stratify patients with clinically non-metastatic PRCC following curative surgery. Methods We studied clinicopathological variables and outcomes of 556 patients, who underwent full resection of sporadic, unilateral, non-metastatic (T1–4, N0–1, M0) PRCC at five institutions. Based on multivariable Fine-Gray competing risks regression models, we developed a prognostic scoring system to predict disease recurrence. This was further evaluated in the 150 PRCC patients recruited to the ASSURE trial. We compared the discrimination, calibration and decision-curve clinical net benefit against the Tumour, Node, Metastasis (TNM) stage group, University of California Integrated Staging System (UISS) and the 2018 Leibovich prognostic groups. Results We developed the VENUSS score from significant variables on multivariable analysis, which were the presence of VEnous tumour thrombus, NUclear grade, Size, T and N Stage. We created three risk groups based on the VENUSS score, with a 5-year cumulative incidence of recurrence equalling 2.9% in low-risk, 15.4% in intermediate-risk and 54.5% in high-risk patients. 91.7% of low-risk patients had oligometastatic recurrent disease, compared to 16.7% of intermediate-risk and 40.0% of high-risk patients. Discrimination, calibration and clinical net benefit from VENUSS appeared to be superior to UISS, TNM and Leibovich prognostic groups. Conclusions We developed and tested a prognostic model for patients with clinically non-metastatic PRCC, which is based on routine pathological variables. This model may be superior to standard models and could be used for tailoring postoperative surveillance and defining inclusion for prospective adjuvant clinical trials." @default.
• W2978156688 created "2019-10-10" @default.
• W2978156688 creator A5006485298 @default.
• W2978156688 creator A5015969462 @default.
• W2978156688 creator A5023375792 @default.
• W2978156688 creator A5023716783 @default.
• W2978156688 creator A5026956341 @default.
• W2978156688 creator A5029812990 @default.
• W2978156688 creator A5030488677 @default.
• W2978156688 creator A5031303345 @default.
• W2978156688 creator A5039495553 @default.
• W2978156688 creator A5060108045 @default.
• W2978156688 creator A5065565113 @default.
• W2978156688 creator A5068678186 @default.
• W2978156688 creator A5069683592 @default.
• W2978156688 creator A5080874150 @default.
• W2978156688 creator A5086299675 @default.
• W2978156688 date "2019-10-03" @default.
• W2978156688 modified "2023-10-10" @default.
• W2978156688 title "The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort" @default.
• W2978156688 cites W1680378644 @default.
• W2978156688 cites W1991408439 @default.
• W2978156688 cites W1992142098 @default.
• W2978156688 cites W1992557526 @default.
• W2978156688 cites W1998628385 @default.
• W2978156688 cites W2010010077 @default.
• W2978156688 cites W2069480574 @default.
• W2978156688 cites W2071727133 @default.
• W2978156688 cites W2083887116 @default.
• W2978156688 cites W2115098571 @default.
• W2978156688 cites W2121827874 @default.
• W2978156688 cites W2128320141 @default.
• W2978156688 cites W2130667129 @default.
• W2978156688 cites W2136085913 @default.
• W2978156688 cites W2161743657 @default.
• W2978156688 cites W2164317031 @default.
• W2978156688 cites W2166339706 @default.
• W2978156688 cites W2171397743 @default.
• W2978156688 cites W2172050766 @default.
• W2978156688 cites W2293077587 @default.
• W2978156688 cites W2327615412 @default.
• W2978156688 cites W2527365254 @default.
• W2978156688 cites W2603926294 @default.
• W2978156688 cites W2606890210 @default.
• W2978156688 cites W2612811682 @default.
• W2978156688 cites W2752842675 @default.
• W2978156688 cites W2768139119 @default.
• W2978156688 cites W2784154144 @default.
• W2978156688 cites W2786438413 @default.
• W2978156688 cites W2792488818 @default.
• W2978156688 doi "https://doi.org/10.1186/s12916-019-1419-1" @default.
• W2978156688 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6775651" @default.
• W2978156688 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31578141" @default.
• W2978156688 hasPublicationYear "2019" @default.
• W2978156688 type Work @default.
• W2978156688 sameAs 2978156688 @default.
• W2978156688 citedByCount "24" @default.
• W2978156688 countsByYear W29781566882020 @default.
• W2978156688 countsByYear W29781566882021 @default.
• W2978156688 countsByYear W29781566882022 @default.
• W2978156688 countsByYear W29781566882023 @default.
• W2978156688 crossrefType "journal-article" @default.
• W2978156688 hasAuthorship W2978156688A5006485298 @default.
• W2978156688 hasAuthorship W2978156688A5015969462 @default.
• W2978156688 hasAuthorship W2978156688A5023375792 @default.
• W2978156688 hasAuthorship W2978156688A5023716783 @default.
• W2978156688 hasAuthorship W2978156688A5026956341 @default.
• W2978156688 hasAuthorship W2978156688A5029812990 @default.
• W2978156688 hasAuthorship W2978156688A5030488677 @default.
• W2978156688 hasAuthorship W2978156688A5031303345 @default.
• W2978156688 hasAuthorship W2978156688A5039495553 @default.
• W2978156688 hasAuthorship W2978156688A5060108045 @default.
• W2978156688 hasAuthorship W2978156688A5065565113 @default.
• W2978156688 hasAuthorship W2978156688A5068678186 @default.
• W2978156688 hasAuthorship W2978156688A5069683592 @default.
• W2978156688 hasAuthorship W2978156688A5080874150 @default.
• W2978156688 hasAuthorship W2978156688A5086299675 @default.
• W2978156688 hasBestOaLocation W29781566881 @default.
• W2978156688 hasConcept C11783203 @default.
• W2978156688 hasConcept C126322002 @default.
• W2978156688 hasConcept C141071460 @default.
• W2978156688 hasConcept C143998085 @default.
• W2978156688 hasConcept C146357865 @default.
• W2978156688 hasConcept C151730666 @default.
• W2978156688 hasConcept C2777472916 @default.
• W2978156688 hasConcept C2779134260 @default.
• W2978156688 hasConcept C71924100 @default.
• W2978156688 hasConcept C72563966 @default.
• W2978156688 hasConcept C86803240 @default.
• W2978156688 hasConceptScore W2978156688C11783203 @default.
• W2978156688 hasConceptScore W2978156688C126322002 @default.
• W2978156688 hasConceptScore W2978156688C141071460 @default.
• W2978156688 hasConceptScore W2978156688C143998085 @default.
• W2978156688 hasConceptScore W2978156688C146357865 @default.
• W2978156688 hasConceptScore W2978156688C151730666 @default.
• W2978156688 hasConceptScore W2978156688C2777472916 @default.
• W2978156688 hasConceptScore W2978156688C2779134260 @default.
• W2978156688 hasConceptScore W2978156688C71924100 @default.
• W2978156688 hasConceptScore W2978156688C72563966 @default.
• W2978156688 hasConceptScore W2978156688C86803240 @default.

• next